Neoleukin Therapeutics

Neoleukin Therapeutics:
Lead program NL-201: is a dual-acting IL-2 and IL-15 agonist immunotherapy for cancer, designed to improve tolerability and activity by eliminating the alpha receptor binding interface (IND completed 4Q20). First de novo protein therapeutic ever created.
Sector/Industry:
Healthcare/Drug Manufacturers
Characteristics:
Based in...
US - Pacific
Clinical Stage
Pre-Clinical Stage
Disease Space
Allergy, Autoimmune, Immuno-Oncology, Infectious Disease, Oncology
Listing
Public, USA
Market Cap
500MM - 1B
Website:
Profiles:
Address:
1616 Eastlake Avenue E
Suit 360
Seattle, WA 98109
United States
Suit 360
Seattle, WA 98109
United States
More info:
My account:
Company Participants at Solebury Trout Management Access SF 2020
- Carl Walkey
- Daniel Silva, VP, Head of Research
- Jonathan G. Drachman, CEO
- Julie Rathbun
- Kamran Alam
Top 10 Holders of Neoleukin Therapeutics, Inc
Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
---|---|---|---|---|---|
Redmile Group LLC | 8.58 | 4,172,686 | 55.87 | 13F | 9/30/20 |
Ecor1 Capital LLC | 7.94 | 3,862,931 | 51.72 | 13F | 9/30/20 |
Baker Bros. Advisors LP | 7.86 | 3,821,740 | 51.17 | 13F | 9/30/20 |
Pictet Asset Management Ltd. | 4.24 | 2,061,283 | 27.60 | 13F | 9/30/20 |
Boxer Capital LLC | 3.09 | 1,501,058 | 20.10 | 13F | 9/30/20 |
Opaleye Management, Inc. | 2.85 | 1,386,300 | 18.56 | 13F | 9/30/20 |
The Vanguard Group, Inc. | 2.32 | 1,129,128 | 15.12 | Funds | 12/31/20 |
BlackRock Fund Advisors | 2.23 | 1,084,591 | 14.52 | 13F | 9/30/20 |
Point72 Asset Management LP (Old) | 2.06 | 999,694 | 13.39 | 13F | 9/30/20 |
Vanguard Group, Inc. (Subfiler) | 2.05 | 995,253 | 13.33 | 13F | 9/30/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.